New Articles of Interest in Endocrine Surgery

July 23, 2018

  1. How I Do It: New Dissector Device Allows for Effective Operative Field in Transoral Endoscopic Thyroid Surgery Using Vestibular Approach.
    Müller V, Mogl M, Seika P, Jöns T, Sauer I, Pratschke J, Anuwong A, Zorron R.
    Sure Innov. 2018 Jul 1:1553350618785281. doi: 10.1177/1553350618785281. [Epub ahead of print]
  2. Extrathyroidal Extension: Does Strap Muscle Invasion Alone Influence Recurrence and Survival in Patients with Differentiated Thyroid Cancer?
    Amit M, Boonsripitayanon M, Goepfert RP, Tam S, Busaidy NL, Cabanillas ME, Dadu R, Varghese J, Waguespack SG, Gross ND, Graham P, Williams MD, Sturgis EM, Zafereo ME.
    Ann Surg Oncol. 2018 Jul 18. doi: 10.1245/s10434-018-6563-x. [Epub ahead of print]
  3. Lack of functional remission in Cushing's syndrome.
    Vermalle M, Alessandrini M, Graillon T, Paladino NC, Baumstarck K, Sebag F, Dufour H, Brue T, Castinetti F.
    Endocrine. 2018 Jul 17. doi: 10.1007/s12020-018-1664-7. [Epub ahead of print]
  4. Metyrapone treatment in Cushing's syndrome: a real-life study.
    Ceccato F, Zilio M, Barbot M, Albiger N, Antonelli G, Plebani M, Watutantrige-Fernando S, Sabbadin C, Boscaro M, Scaroni C
    Endocrine. 2018 Jul 16. doi: 10.1007/s12020-018-1675-4. [Epub ahead of print]
  5. Low trabecular bone score in postmenopausal women with differentiated thyroid carcinoma after long-term TSH suppressive therapy.
    Dominguez MLM, Iglesias SG, Arroba CM, Álvarez BL, Diaz-Guerra GM, Martinez-Pueyo JI, Herrero EF, Carranza FH.
    Endocrine. 2018 Jul 16. doi: 10.1007/s12020-018-1671-8. [Epub ahead of print]
  6. Should Symptoms Be Considered an Indication for Parathyroidectomy in Primary Hyperparathyroidism?
    McDow AD, Sippel RS
    Clin Med Insights Endocrinol Diabetes. 2018 Jun 27;11:1179551418785135. doi: 10.1177/1179551418785135. eCollection 2018. Review.
  7. The effect of surgery on fat mass, lipid and glucose metabolism in mild primary hyperparathyroidism.
    Godang K, Lundstam K, Mollerup C, Fougner SL, Pernow Y, Nordenström J, Rosen T, Jansson S, Hellström M, Bollerslev J, Heck A.
    Endocr Connect. 2018 Jul 16. pii: EC-18-0259. doi: 10.1530/EC-18-0259. [Epub ahead of print]
  8. To admit or not to admit? Experience with outpatient thyroidectomy for Graves' disease in a high-volume tertiary care center.
    Mallick R, Asban A, Chung S, Hur J, Lindeman B, Chen H.
    Am J Surg. 2018 Jul 10. pii: S0002-9610(18)30805-5. doi: 10.1016/j.amjsurg.2018.07.002. [Epub ahead of print]
  9. Morbidity in parathyroid surgery for renal disease is under reported: a comparison of outcomes with primary hyperparathyroidism.
    Nastos K, Constantinides V, Mizamtsidi M, Duncan N, Tolley N, Palazzo F.
    Ann R Coll Surg Engl. 2018 Jul;100(6):436-442. doi: 10.1308/rcsann.2018.0032.
  10. Normocalcaemic primary hyperparathyroidism: a diagnostic and therapeutic algorithm.
    Gómez-Ramírez J, Mihai R.
    Langenbecks Arch Surg. 2017 Nov;402(7):1103-1108. doi: 10.1007/s00423-017-1617-2. Epub 2017 Aug 19. Review.

July 13, 2018

  1. Pheochromocytoma and Paraganglioma in Neurofibromatosis type 1: frequent surgeries and cardiovascular crises indicate the need for screening.
    Petr EJ, Else T.
    Clin Diabetes Endocrinol. 2018 Jun 22;4:15. doi: 10.1186/s40842-018-0065-4. eCollection 2018
  2. Improved outcomes for papillary thyroid microcarcinoma care: active surveillance and case volume.
    Freni F, Galletti B, Galletti F, Dionigi G.
    Ther Adv Endocrinol Metab. 2018 Jul;9(7):185-186. doi: 10.1177/2042018818773609. Epub 2018 May 4. No abstract available.
  3. Lessons Learned From a Faulty Transoral Endoscopic Thyroidectomy Vestibular Approach.
    Zhang D, Wu CW, Inversini D, Kim HY, Anuwong A, Bacuzzi A, Dionigi G.
    Surg Laparosc Endosc Percutan Tech. 2018 Jul 2. doi: 10.1097/SLE.0000000000000555. [Epub ahead of print]
  4. Do Anticoagulation Medications Increase The Risk of Hematoma in Ultrasound Guided Fine Needle Aspiration of Thyroid Lesions?
    Khadra H, Kholmatov R, Monlezun D, Kandil E.
    Endocrine. 2018 Jul 3. doi: 10.1111/cyt.12608. [Epub ahead of print]
  5. Sentinel lymph node biopsy in small papillary thyroid cancer. A review on novel surgical techniques.
    Garau LM, Rubello D, Ferretti A, Boni G, Volterrani D, Manca G.
    Endocrine. 2018 Jul 2. doi: 10.1007/s12020-018-1658-5. [Epub ahead of print]
  6. Perioperative serum cortisol levels in ACTH sufficient and ACTH deficient patients during transsphenoidal surgery of pituitary adenoma.
    Borg H, Siesjö P, Kahlon B, Fjalldal S, Erfurth EM.
    Endocrine. 2018 Jul 2. doi: 10.1007/s12020-018-1655-8. [Epub ahead of print]
  7. Therapeutic plasmapheresis in thyrotoxic patients.
    Simsir IY, Ozdemir M, Duman S, Erdogan M, Donmez A, Ozgen AG.
    Endocrine. 2018 Jul 2. doi: 10.1007/s12020-018-1661-x. [Epub ahead of print]
  8. The safety of anaesthetising biochemically hyperthyroid patients undergoing thyroidectomy-a retrospective cohort study.
    Short HL, Tamatea J, Conaglen HM, Furlonger AJ, Meyer-Rochow GY, Conaglen JV, Elston MS
    Anaesth Intensive Care. 2018 Jul;46(4):396-399.
  9. Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement.
    Mantovani G, Bastepe M, Monk D, de Sanctis L, Thiele S, Usardi A, Ahmed SF, Bufo R, Choplin T, De Filippo G, Devernois G, Eggermann T, Elli FM, Freson K, García Ramirez A, Germain-Lee EL, Groussin L, Hamdy N, Hanna P, Hiort O, Jüppner H, Kamenický P, Knight N, Kottler ML, Le Norcy E, Lecumberri B, Levine MA, Mäkitie O, Martin R, Martos-Moreno GÁ, Minagawa M, Murray P, Pereda A, Pignolo R, Rejnmark L, Rodado R, Rothenbuhler A, Saraff V, Shoemaker AH, Shore EM, Silve C, Turan S, Woods P, Zillikens MC, Perez de Nanclares G, Linglart A.
    Nat Rev Endocrinol. 2018 Jun 29. doi: 10.1038/s41574-018-0042-0. [Epub ahead of print] Review.
  10. Preventing hypoparathyroidism after total thyroidectomy.
    Serpell JW.
    ANZ J Surg. 2018 Mar;88(3):127-128. doi: 10.1111/ans.14235. No abstract available.

July 5, 2018

  1. TERT promoter hypermethylation is associated with poor prognosis in adrenocortical carcinoma.
    Svahn F, Paulsson JO, Stenman A, Fotouhi O, Mu N, Murtha TD, Korah R, Carling T, Bäckdahl M, Wang N, Juhlin CC, Larsson C.
    Int J Mol Med. 2018 Jun 20. doi: 10.3892/ijmm.2018.3735. [Epub ahead of print]
  2. Influence of neural monitoring during thyroid surgery on nerve integrity and postoperative vocal function.
    Engelsman AF, Warhurst S, Fraser S, Novakovic D, Sidhu SB.
    BJS Open. 2018 Apr 25;2(3):135-141. doi: 10.1002/bjs5.50. eCollection 2018 Jun.
  3. Treatment of multiresistant prolactinomas with a combination of cabergoline and octreotide LAR.
    Sosa-Eroza E, Espinosa E, Ramírez-Rentería C, Mendoza V, Arreola R, Mercado M.
    Endocrine. 2018 Jun 11. doi: 10.1007/s12020-018-1638-9. [Epub ahead of print]
  4. AHNS Series: Do you know your guidelines? AHNS Endocrine Section Consensus Statement: State-of-the-art thyroid surgical recommendations in the era of noninvasive follicular thyroid neoplasm with papillary-like nuclear features.
    Ferris RL, Nikiforov Y, Terris D, Seethala RR, Ridge JA, Angelos P, Duh QY, Wong R, Sabra MM, Fagin JA, McIver B, Bernet VJ, Harrell RM, Busaidy N, Cibas ES, Faquin WC, Sadow P, Baloch Z, Shindo M, Orloff L, Davies L, Randolph GW.
    Head Neck. 2018 Jun 26. doi: 10.1002/hed.25141. [Epub ahead of print]
  5. Cushing's Disease in Older Patients: Presentation and Outcome.<
    Qiao N, Swearingen B, Tritos NA.
    Clin Endocrinol (Oxf). 2018 Jun 25. doi: 10.1111/cen.13799. [Epub ahead of print]
  6. Characterization of adrenocortical tumors by <sup>18</sup>F-FDG PET/CT: Does steroid hormone hypersecretion status modify the uptake pattern?
    Paladino NC, Guérin C, Lowery A, Attard A, Essamet W, Slotema E, Morange I, Castinetti F, Brue T, Loundou A, Taïeb D, Sebag F.
    Surg Oncol. 2018 Jun;27(2):231-235. doi: 10.1016/j.suronc.2018.04.003. Epub 2018 Apr 23.
  7. How academically productive are endocrine surgeons in the United States?
    Garner EF, Valsangkar NP, Wang TN, Porterfield JR, Koniaris LG, Chen H.
    J Surg Res. 2018 Sep;229:122-126. doi: 10.1016/j.jss.2018.03.066. Epub 2018 Apr 23.
  8. Retroperitoneal laparoscopic adrenalectomy with transient renal artery occlusion for large adrenal tumors (≥8 cm).
    Gong B, Ma M, Xie W, Yang X, Sun T.
    J Surg Oncol. 2018 Apr;117(5):1066-1072. doi: 10.1002/jso.25002. Epub 2018 Feb 15.
  9. Skeletal fragility induced by overtreatment of adrenal insufficiency.
    Falhammar H.
    Endocrine. 2018 Feb;59(2):239-241. doi: 10.1007/s12020-017-1501-4. Epub 2017 Dec 23
  10. Standing thyroidectomy in 10 horses.
    Marcatili M, Voss SJ, Pollock PJ.
    Vet Surg. 2018 Jan;47(1):86-92. doi: 10.1111/vsu.12744. Epub 2017 Nov 8.

June 26, 2018

  1. Optimal combination of treatment modality to increase survival in patients with anaplastic thyroid carcinoma: A STROBE compliant retrospective study.
    Lee JH, Ahn HK, Seok JY, Lee KC, Chun YS, Chung YS, Lee YD
    Medicine (Baltimore). 2018 Jun;97(25):e11037. doi: 10.1097/MD.0000000000011037.
  2. Incidence and management of postoperative hyperglycemia in patients undergoing insulinoma resection.
    Nockel P, Tirosh A, El Lakis M, Gaitanidis A, Merkel R, Patel D, Nilubol N, Sadowski SM, Cochran C, Gorden P, Kebebew E.
    Endocrine. 2018 Jun 19. doi: 10.1007/s12020-018-1633-1. [Epub ahead of print]
  3. Parathyroid carcinoma in multiple endocrine neoplasm type 1 syndrome: case report and systematic literature review.
    Di Meo G, Sgaramella LI, Ferraro V, Prete FP, Gurrado A, Testini M.
    Clin Exp Med. 2018 Jun 20. doi: 10.1007/s10238-018-0512-7. [Epub ahead of print]
  4. Clinicopathological description of 43 oncocytic adrenocortical tumors: importance of Ki-67 in histoprognostic evaluation.
    Renaudin K, Smati S, Wargny M, Al Ghuzlan A, Aubert S, Leteurtre E, Patey M, Sibony M, Sturm N, Tissier F, Amar L, Bertherat J, Berthozat C, Chabre O, Do Cao C, Haissaguerre M, Pierre P, Briet C, Vezzosi D, Lifante JC, Pattou F, Mirallie E, Baudin E, Cariou B, Libe R, Drui D; for Comete-Cancer Network.
    Mod Pathol. 2018 Jun 19. doi: 10.1038/s41379-018-0077-8. [Epub ahead of print]
  5. Long non-coding RNA BANCR regulates cancer stem cell markers in papillary thyroid cancer via the RAF/MEK/ERK signaling pathway.<
    Wang Y, Lin X, Fu X, Yan W, Lin F, Kuang P, Luo Y, Lin E, Hong X, Wu G.
    Oncol Rep. 2018 Jun 18. doi: 10.3892/or.2018.6502. [Epub ahead of print]
  6. Re-operative Surgery for Pheochromocytoma-Paraganglioma: Analysis of 13 Cases from a Single Institution.
    Sonbare DJ, Abraham DT, Rajaratnam S, Thomas N, Manipadam MT, Pai R, Jacob PM.
    Indian J Surg. 2018 Apr;80(2):123-127. doi: 10.1007/s12262-017-1658-3. Epub 2017 Jun 5.
  7. Indeterminate Thyroid Nodule: Mystery Continues Despite Recent Advances.
    Joshi A, Agrawal R.
    Indian J Endocrinol Metab. 2018 Mar-Apr;22(2):290. doi: 10.4103/ijem.IJEM_604_17. No abstract available.
  8. Survival of aggressive variants of papillary thyroid carcinoma in patients under 55 years old: a SEER population-based retrospective analysis.
    Feng J, Shen F, Cai W, Gan X, Deng X, Xu B.
    Endocrine. 2018 Jun 16. doi: 10.1007/s12020-018-1644-y. [Epub ahead of print]
  9. The 2017 WHO classification of pituitary adenoma: overview and comments.
    Inoshita N, Nishioka H.
    Brain Tumor Pathol. 2018 Apr;35(2):51-56. doi: 10.1007/s10014-018-0314-3. Epub 2018 Apr 23. Review.
  10. Initial Clinical Investigation of [18F]Tetrafluoroborate PET/CT in Comparison to [124I]Iodine PET/CT for Imaging Thyroid Cancer.
    Samnick S, Al-Momani E, Schmid JS, Mottok A, Buck AK, Lapa C.
    Clin Nucl Med. 2018 Mar;43(3):162-167. doi: 10.1097/RLU.0000000000001977.

June 21, 2018

  1. DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatment.
    Conemans EB, Lodewijk L, Moelans CM, Offerhaus GJA, Pieterman CRC, Morsink FH, Dekkers OM, de Herder WW, Hermus AR, van der Horst-Schrivers ANA, Drent ML, Bisschop PH, Havekes B, Brosens LAA, Dreijerink KMA, Borel Rinkes IHM, Timmers HTM, Valk GD, Vriens MR.
    Eur J Endocrinol. 2018 Jun 14. pii: EJE-18-0195. doi: 10.1530/EJE-18-0195. [Epub ahead of print]
  2. Quality of life in multiple endocrine neoplasia type 2A compared with normative and disease populations.
    Mongelli MN, Peipert BJ, Goswami S, Helenowski I, Yount SE, Sturgeon C.
    Surgery. 2018 Jun 11. pii: S0039-6060(18)30213-7. doi: 10.1016/j.surg.2018.04.036. [Epub ahead of print]
  3. Telomerase reverse transcriptase induced thyroid carcinoma cell proliferation through PTEN/AKT signaling pathway.
    Zhang H, Hu N.
    Mol Med Rep. 2018 Jun 1. doi: 10.3892/mmr.2018.9119. [Epub ahead of print]
  4. NRG1 regulates redox homeostasis via NRF2 in papillary thyroid cancer.
    Zhang TT, Qu N, Sun GH, Zhang L, Wang YJ, Mu XM, Wei WJ, Wang YL, Wang Y, Ji QH, Zhu YX, Shi RL.
    Int J Oncol. 2018 May 31. doi: 10.3892/ijo.2018.4426. [Epub ahead of print]
  5. Appetite changes reveal depression subgroups with distinct endocrine, metabolic, and immune states.
    Simmons WK, Burrows K, Avery JA, Kerr KL, Taylor A, Bodurka J, Potter W, Teague TK, Drevets WC.
    Mol Psychiatry. 2018 Jun 13. doi: 10.1038/s41380-018-0093-6. [Epub ahead of print]
  6. Possible delayed diagnosis and treatment of metastatic differentiated thyroid cancer by adopting the 2015 ATA guidelines.
    Albano D, Bertagna F, Bonacina M, Durmo R, Cerudelli E, Gazzilli M, Panarotto MB, Formenti AM, Mazziotti G, Giustina A, Giubbini R.
    Eur J Endocrinol. 2018 Jun 13. pii: EJE-18-0253. doi: 10.1530/EJE-18-0253. [Epub ahead of print]
  7. Recent Topics Around Multiple Endocrine Neoplasia Type 1.
    Marx SJ.
    J Clin Endocrinol Metab. 2018 Apr 1;103(4):1296-1301. doi: 10.1210/jc.2017-02340.
  8. Prognostic Evaluations Tailored to Specific Gastric Neuroendocrine Neoplasms: Analysis Of 200 Cases with Extended Follow-Up.
    Vanoli A, La Rosa S, Miceli E, Klersy C, Maragliano R, Capuano F, Persichella A, Martino M, Inzani F, Luinetti O, Di Sabatino A, Sessa F, Paulli M, Corazza GR, Rindi G, Bordi C, Capella C, Solcia E.
    Neuroendocrinology. 2018 Jun 12:1-13. doi: 10.1159/000489902. [Epub ahead of print]
  9. Transcutaneously refillable, 3D-printed biopolymeric encapsulation system for the transplantation of endocrine cells.
    Farina M, Chua CYX, Ballerini A, Thekkedath U, Alexander JF, Rhudy JR, Torchio G, Fraga D, Pathak RR, Villanueva M, Shin CS, Niles JA, Sesana R, Demarchi D, Sikora AG, Acharya GS, Gaber AO, Nichols JE, Grattoni A.
    Biomaterials. 2018 May 30;177:125-138. doi: 10.1016/j.biomaterials.2018.05.047. [Epub ahead of print]
  10. SLC12A7 alters adrenocortical carcinoma cell adhesion properties to promote an aggressive invasive behavior.
    Brown TC, Murtha TD, Rubinstein JC, Korah R, Carling T.
    Cell Commun Signal. 2018 Jun 8;16(1):27. doi: 10.1186/s12964-018-0243-0.

June 13, 2018

  1. New Insights in Cushing Disease Treatment With Focus on a Derivative of Vitamin A.
    Fuertes M, Tkatch J, Rosmino J, Nieto L, Guitelman MA, Arzt E.
    Front Endocrinol (Lausanne). 2018 May 24;9:262. doi: 10.3389/fendo.2018.00262. eCollection 2018. Review.
  2. Highly specific preoperative selection of solitary parathyroid adenoma cases in primary hyperparathyroidism by quantitative image analysis of the early-phase Technetium-99m sestamibi scan.
    Kim D, Rhodes JA, Hashim JA, Rickabaugh L, Brams DM, Pinkus E, Dou Y.
    J Med Imaging Radiat Oncol. 2018 Jun 7. doi: 10.1111/1754-9485.12753. [Epub ahead of print]
  3. Surviving ectopic Cushing's syndrome: Quality of life, cardiovascular and metabolic outcomes in comparison to Cushing's disease during long-term follow-up.
    Osswald A, Deutschbein T, Berr CM, Plomer E, Mickisch A, Ritzel K, Schopohl J, Beuschlein F, Fassnacht M, Hahner S, Reincke M.
    Eur J Endocrinol. 2018 Jun 6. pii: EJE-18-0212. doi: 10.1530/EJE-18-0212. [Epub ahead of print]
  4. Adrenal Crises in Children: Perspectives and Research Directions.
    Rushworth RL, Torpy DJ, Stratakis CA, Falhammar H.
    Horm Res Paediatr. 2018 Jun 6:1-11. doi: 10.1159/000481660. [Epub ahead of print]
  5. A rural perspective on minimally invasive parathyroidectomy: optimal preoperative imaging and patient outcomes.
    Binks M, Burrows D, Littlejohn D.
    ANZ J Surg. 2018 Jun 5. doi: 10.1111/ans.14374. [Epub ahead of print]
  6. A case-control study of exposure to organophosphate flame retardants and risk of thyroid cancer in women.
    Deziel NC, Yi H, Stapleton HM, Huang H, Zhao N, Zhang Y.
    BMC Cancer. 2018 Jun 5;18(1):637. doi: 10.1186/s12885-018-4553-9.
  7. Histology-proven recurrence in the lateral or central neck after systematic neck dissection for medullary thyroid cancer.
    Machens A, Lorenz K, Dralle H.
    Endocrine. 2018 Jun 5. doi: 10.1007/s12020-018-1625-1. [Epub ahead of print]
  8. Current Knowledge on Endocrine Disrupting Chemicals (EDCs) from Animal Biology to Humans, from Pregnancy to Adulthood: Highlights from a National Italian Meeting.
    Street ME, Angelini S, Bernasconi S, Burgio E, Cassio A, Catellani C, Cirillo F, Deodati A, Fabbrizi E, Fanos V, Gargano G, Grossi E, Iughetti L, Lazzeroni P, Mantovani A, Migliore L, Palanza P, Panzica G, Papini AM, Parmigiani S, Predieri B, Sartori C, Tridenti G, Amarri S.
    Int J Mol Sci. 2018 Jun 2;19(6). pii: E1647. doi: 10.3390/ijms19061647. Review.
  9. TERT promoter mutational screening as a tool to predict malignant behaviour in follicular thyroid tumours-three examples from the clinical routine.
    Hysek M, Paulsson JO, Wang N, Jatta K, Lindh C, Fuentes-Martinez N, Shabo I, Zedenius J, Juhlin CC.
    Virchows Arch. 2018 Jun 2. doi: 10.1007/s00428-018-2386-1. [Epub ahead of print]
  10. Natural History of Contralateral Nodules After Lobectomy in Patients With Papillary Thyroid Carcinoma.
    Ritter A, Bachar G, Hirsch D, Benbassat C, Katz O, Kochen N, Diker-Cohen T, Akirov A, Shimon I, Robenshtok E.
    J Clin Endocrinol Metab. 2018 Feb 1;103(2):407-414. doi: 10.1210/jc.2017-01616.

June 6, 2018

  1. Is serum TSH a biomarker of thyroid carcinoma in patients residing in a mildly iodine-deficient area?
    Swan KZ, Nielsen VE, Godballe C, Thrane JF, Mortensen MR, Schytte S, Pedersen HB, Christiansen P, Bonnema SJ. Endocrine. 2018 May 31. doi: 10.1007/s12020-018-1637-x. [Epub ahead of print]
  2. Effectiveness of medical treatment for Cushing's syndrome: a systematic review and meta-analysis.
    Broersen LHA, Jha M, Biermasz NR, Pereira AM, Dekkers OM.
    Pituitary. 2018 May 31. doi: 10.1007/s11102-018-0897-z. [Epub ahead of print]
  3. Comparing the safety of harmonic ACE and ACE+ around the recurrent laryngeal nerve in swine models.
    Kim HK, Chai YJ, Lee HY, Kim HY, Dionigi G.
    Ann Surg Treat Res. 2018 Jun;94(6):285-290. doi: 10.4174/astr.2018.94.6.285. Epub 2018 May 29.
  4. The Outcome of Papillary Thyroid Cancer Associated with Graves' Disease: A Case Control Study.
    Menon R, Nair CG, Babu M, Jacob P, Krishna GP.
    J Thyroid Res. 2018 May 8;2018:8253094. doi: 10.1155/2018/8253094. eCollection 2018.
  5. Molecular evaluation of a sporadic paraganglioma with concurrent IDH1 and ATRX mutations.
    Zhang J, Jiang J, Luo Y, Li X, Lu Z, Liu Y, Huang J, Hou Y, Pang Y, Sun MYF, Wang TS, Evans DB, Pacak K, Zhuang Z, Gao X. Endocrine. 2018 May 30. doi: 10.1007/s12020-018-1617-1. [Epub ahead of print]
  6. Diabetes after pancreaticoduodenectomy: can we predict it?
    Singh AN, Pal S, Kilambi R, Madhusudhan KS, Dash NR, Tandon N, Sahni P.
    J Surg Res. 2018 Jul;227:211-219. doi: 10.1016/j.jss.2018.02.010. Epub 2018 Mar 20.
  7. Functional adrenal cortex preservation: A good reason for posterior retroperitoneal endoscopic approach.
    Vidal Ó, Delgado-Oliver E, Díaz Del Gobbo R, Hanzu F, Squarcia M, Martínez D, Fuster D, Fondevila C.
    Cir Esp. 2018 May 24. pii: S0009-739X(18)30137-4. doi: 10.1016/j.ciresp.2018.04.008. [Epub ahead of print] English, Spanish
  8. Decreasing Use of Radioactive Iodine for Low-Risk Thyroid Cancer in California, 1999 to 2015.
    Park KW, Wu JX, Du L, Leung AM, Yeh MW, Livhits MJ.
    J Clin Endocrinol Metab. 2018 Mar 1;103(3):1095-1101. doi: 10.1210/jc.2017-02269.
  9. Typical carcinoid involving the main carina managed with arterial embolisation, endobronchial resection and ablation, ultimately followed by carinal resection.
    Tan MWY, Leong P, Antippa P, Jennings BR.
    BMJ Case Rep. 2017 Sep 28;2017. pii: bcr-2017-221800. doi: 10.1136/bcr-2017-221800.
  10. Surgery Significantly Improves Neurocognition, Sleep, and Blood Pressure in Primary Hyperparathyroidism: A 3-Year Prospective Follow-Up Study.
    Storvall S, Ryhänen EM, Heiskanen I, Sintonen H, Roine RP, Schalin-Jäntti C.
    Horm Metab Res. 2017 Oct;49(10):772-777. doi: 10.1055/s-0043-118347. Epub 2017 Sep 18.

June 1, 2018

  1. Transoral endoscopic thyroidectomy vestibular approach: a preliminary framework for assessment and safety.
    Russell J, Anuwong A, Dionigi G, Inabnet WB, Kim HY, Randolph GW, Richmon JD, Tufano RP.
    Thyroid. 2018 May 23. doi: 10.1089/thy.2017.0642. [Epub ahead of print]
  2. Prophylactic Central Compartment Neck Dissection in Papillary Thyroid Cancer and Effect on Locoregional Recurrence.
    Hughes DT, Rosen JE, Evans DB, Grubbs E, Wang TS, Solórzano CC
    Ann Surg Oncol. 2018 May 21. doi: 10.1245/s10434-018-6528-0. [Epub ahead of print]
  3. Genotypic characteristics and their association with phenotypic characteristics of hereditary medullary thyroid carcinoma in Korea.
    Jung KY, Kim SM, Kim MJ, Cho SW, Kim BW, Lee YS, Jeong JJ, Nam KH, Chung WY, Lee KE, Chung EJ, Kim HJ, Park DJ, Sung MW, Park CS, Cho BY, Park YJ, Chang HS.
    Surgery. 2018 May 17. pii: S0039-6060(18)30142-9. doi: 10.1016/j.surg.2018.03.018. [Epub ahead of print]
  4. Over-diagnosis of potential malignant behavior in MEN 2A-associated pheochromocytomas using the PASS and GAPP algorithms.
    Stenman A, Zedenius J, Juhlin CC.
    Langenbecks Arch Surg. 2018 May 19. doi: 10.1007/s00423-018-1679-9. [Epub ahead of print]
  5. Anaplastic thyroid cancer and hyperfractionated accelerated radiotherapy (HART) with and without surgery.
    Jacobsen AB, Grøholt KK, Lorntzsen B, Osnes TA, Falk RS, Sigstad E.
    Eur Arch Otorhinolaryngol. 2017 Dec;274(12):4203-4209. doi: 10.1007/s00405-017-4764-8. Epub 2017 Oct 10
  6. Disease Severity at Presentation in Patients with Disease-Related Mortality from Differentiated Thyroid Cancer: Implications for the 2015 ATA Guidelines.
    Robenshtok E, Nachalon Y, Benbassat C, Hirsch D, Shimon I, Grossman A, Diker-Cohen T, Akirov A, Popovtzer A.Eur J Thyroid. 2017 Sep;27(9):1171-1176. doi: 10.1089/thy.2017.0040.
  7. Thyrotropin Suppressive Therapy for Low-Risk Small Thyroid Cancer: A Propensity Score-Matched Cohort Study.
    Park S, Kim WG, Han M, Jeon MJ, Kwon H, Kim M, Sung TY, Kim TY, Kim WB, Hong SJ, Shong YK
    Thyroid. 2017 Sep;27(9):1164-1170. doi: 10.1089/thy.2017.0177. Epub 2017 Aug 8
  8. Sorafenib in Japanese Patients with Locally Advanced or Metastatic Medullary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma.
    Ito Y, Onoda N, Ito KI, Sugitani I, Takahashi S, Yamaguchi I, Kabu K, Tsukada K.
    Thyroid. 2017 Sep;27(9):1142-1148. doi: 10.1089/thy.2016.0621. Epub 2017 Jul 24.
  9. Imaging of Parathyroid Glands in End Stage Renal Disease.
    Sharma J, Halkar R, Weber CJ.
    Semin Dial. 2017 Jul;30(4):369-372. doi: 10.1111/sdi.12608. Epub 2017 May 30. Review.
  10. Hyperkalemia in both surgically and medically treated patients with primary aldosteronism.
    Wada N, Shibayama Y, Umakoshi H, Ichijo T, Fujii Y, Kamemura K, Kai T, Sakamoto R, Ogo A, Matsuda Y, Fukuoka T, Tsuiki M, Suzuki T, Naruse M.
    J Hum Hypertens. 2017 Oct;31(10):627-632. doi: 10.1038/jhh.2017.38. Epub 2017 May 25.


May 24, 2018

  1. Risk Factors for Central Neck Lymph Node Metastases in Follicular Variant vs. Classic Papillary Thyroid Carcinoma.
    Raffaelli M, De Crea C, Sessa L, Fadda G, Lombardi CP, Bellantone R.
    Endocrine. 2018 May 16. doi: 10.1007/s12020-018-1607-3. [Epub ahead of print]
  2. Risk Factors Associated with Intrathyroid Extension of Thyroid Microcarcinomas.
    Slijepcevic N, Zivaljevic V, Diklic A, Jovanovic M, Oluic B, Paunovic I.
    Langenbecks Arch Surg. 2018 May 17. doi: 10.1007/s00423-018-1680-3. [Epub ahead of print]
  3. Surgical Outcomes Following Repeat Transsphenoidal Surgery for Nonfunctional Pituitary Adenomas: A Retrospective Comparative Study.
    Bakhsheshian J, Wheeler S, Strickland BA, Pham MH, Rennert RC, Carmichael J, Weiss M, Zada G.
    Oper Neurosurg (Hagerstown). 2018 May 15. doi: 10.1093/ons/opy078. [Epub ahead of print]
  4. Endoscopic vs. Microscopic Transsphenoidal Surgery for Cushing’s Disease: A Systematic Review and Meta-Analysis.
    Broersen LHA, Biermasz NR, van Furth WR, de Vries F, Verstegen MJT, Dekkers OM, Pereira AM.
    Pituitary. 2018 May 16. doi: 10.1007/s11102-018-0893-3. [Epub ahead of print]
  5. C-Arm Compound Tomography- Assisted Venous Sampling Improved Right Adrenal Vein Cannulation and Sampling Quality in Primary Aldosteronism.
    Park CH, Hong N, Han K, Kang SW, Lee CR, Park S, Rhee Y.
    Endocrinol Metab (Seoul). 2018 May 4. [Epub ahead of print]
  6. Management of Endocrine Disease: Which Metabolic Procedure? Comparing Outcomes in Sleeve Gastrectomy and Roux-en Y Gastric Bypass.
    Billeter AT, de la Garza Herrera J, Scheurlen KM, Nickel F, Billmann F, Müller-Stich B.
    Eur J Endocrinol. 2018 May 15. pii: EJE-18-0009. doi: 10.1530/EJE-18-0009. [Epub ahead of print]
  7. Differential GIP/GLP-1 Intestinal Cell Distribution in Diabetics’ Yields Distinctive Rearrangements Depending on Roux-en-Y Biliopancreatic Limb Length.
    Palha AM, Pereira SS, Costa MM, Morais T, Maia AF, Guimarães M, Nora M, Monteiro MP.
    J Cell Biochem. 2018 May 15. doi: 10.1002/jcb.27062. [Epub ahead of print]
  8. Co-Existence of <i>BRAF<sup>V600E</sup</i> and <i>TERT</i> Promoter Mutations in Papillary Thyroid Carcinoma is Associated with Tumor Aggressiveness, but not with Lymph Node Metastasis.
    Ren H, Shen Y, Hu D, He W, Zhou J, Cao Y, Mao Y, Dou Y, Xiong W, Xiao Q, Zhang Y, Su X.
    Cancer Manag Res. 2018 May 3;10:1005-1013. doi: 10.2147/CMAR.S159583. eCollection 2018.
  9. Selective Parathyroid Venous Sampling in Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis.
    Ibraheem K, Toraih EA, Haddad AB, Farag M, Randolph GW, Kandil E.
    Laryngoscope. 2018 May 14. doi: 10.1002/lary.27213. [Epub ahead of print] Review.
  10. Early Outcomes in Transoral Vestibular Thyroidectomy: Robotic Versus Endoscopic Techniques.
    Razavi CR, Khadem MGA, Fondong A, Clark JH, Richmon JD, Tufano RP, Russell JO.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25323. [Epub ahead of print]

 

May 12, 2018

April 30, 2018

  1. Endocrine Surgery in the Geriatric Population. McIntire JB, McCammon S, Mong ER.  Otolaryngol Clin North Am. 2018 Apr 23. pii: S0030-6665(18)30052-5. 
  2. American Thyroid Association Guidelines and Statements: Past, Present, and Future. Sawka AM, Carty SE, Haugen BR, Hennessey JV, Kopp PA, Pearce EN, Sosa JA, Tufano RP, Jonklaas J. Thyroid. 2018 Apr 26. doi: 10.1089/thy.2018.0070. [Epub ahead of print]
  3. Laparoscopic versus robotic adrenalectomy: a review of the national inpatient sample. Samreen S, Fluck M, Hunsinger M, Wild J, Shabahang M, Blansfield JA. J Robot Surg. 2018 Apr 25. doi: 10.1007/s11701-018-0808-3. 
  4. Patient Frailty Should Be Used to Individualize Treatment Decisions in Primary Hyperparathyroidism. Seib CD, Chomsky-Higgins K, Gosnell JE, Shen WT, Suh I, Duh QY, Finlayson E. World J Surg. 2018 Apr 25. doi: 10.1007/s00268-018-4629-3. 
  5. Predictive Factors of Secondary Normocalcemic Hyperparathyroidism after Roux-en-Y Gastric Bypass. Casella C, Molfino S, Mittempergher F, Cappelli C, Portolani N. Int J Endocrinol. 2018 Mar 6;2018:5010287. doi: 10.1155/2018/5010287. eCollection 2018.
  6. Challenging pre-surgical localization of hyperfunctioning parathyroid glands in primary hyperparathyroidism: the added value of 18F-Fluorocholine PET/CT. Grimaldi S, Young J, Kamenicky P, Hartl D, Terroir M, Leboulleux S, Berdelou A, Hadoux J, Hescot S, Remy H, Baudin E, Schlumberger M, Deandreis D. Eur J Nucl Med Mol Imaging. 2018 Apr 22. doi: 10.1007/s00259-018-4018-z. [Epub ahead of print]
  7. Adrenocorticotropic Hormone Secreting Pheochromocytoma Underlying Glucocorticoid Induced Pheochromocytoma Crisis. Geva GA, Gross DJ, Mazeh H, Atlan K, Ben-Dov IZ, Fischer M. Case Rep Endocrinol. 2018 Feb 20;2018:3963274. doi: 10.1155/2018/3963274. eCollection 2018.
  8. Prognostic significance of gross extrathyroidal extension invading only strap muscles in differentiated thyroid carcinoma. Park SY, Kim HI, Kim JH, Kim JS, Oh YL, Kim SW, Chung JH, Jang HW, Kim TH. Br J Surg. 2018 Apr 17. doi: 10.1002/bjs.10830. [Epub ahead of print]
  9. Prophylactic thyroidectomy in children with multiple endocrine neoplasia type 2. Prete FP, Abdel-Aziz T, Morkane C, Brain C, Kurzawinski TR; MEN2 in Children UK Collaborative Group. Br J Surg. 2018 Apr 17. doi: 10.1002/bjs.10856. [Epub ahead of print]
  10. Quality of life in thyroid cancer-assessment of physician perceptions. James BC, Aschebrook-Kilfoy B, White MG, Applewhite MK, Kaplan SP, Angelos P, Kaplan EL, Grogan RH. J Surg Res. 2018 Jun;226:94-99. doi: 10.1016/j.jss.2017.11.069. Epub 2018 Feb 15.